Nucleotides in neuroregeneration and neuroprotection  by Miras-Portugal, M. Teresa et al.
lable at ScienceDirect
Neuropharmacology 104 (2016) 243e254Contents lists avaiNeuropharmacology
journal homepage: www.elsevier .com/locate/neuropharmInvited reviewNucleotides in neuroregeneration and neuroprotection
M. Teresa Miras-Portugal a, Rosa Gomez-Villafuertes a, *, Javier Gualix a,
Juan Ignacio Diaz-Hernandez a, Antonio R. Artalejo b, Felipe Ortega a,
Esmerilda G. Delicado a, Raquel Perez-Sen a
a Department of Biochemistry and Molecular Biology IV, Veterinary School, Universidad Complutense of Madrid, 28040 Madrid, Spain
b Department of Toxicology and Pharmacology, Veterinary School, Universidad Complutense of Madrid, 28040 Madrid, Spaina r t i c l e i n f o
Article history:
Received 29 July 2015
Received in revised form
1 September 2015
Accepted 2 September 2015









MAPK signalingAbbreviations: (AIS), axon initial segment; (ATF3
ﬁbroblast growth factor; (BzATP), 30-O-(4-benzoyl)b
response element-binding protein; (DINE), damage-in
cells; (epSPCis), ependymal stem/progenitor cells aft
adhesion molecule 1; (IGF-I), insulin-like growth facto
D-glucamine; (Nrf-2), nuclear factor erythroid 2-relat
phosphoinositide 3-kinase; (PKC), protein kinase C; (
and activator of transcription 3; (SVZ), subventricular
* Corresponding author.
E-mail address: marosa@vet.ucm.es (R. Gomez-Vil
http://dx.doi.org/10.1016/j.neuropharm.2015.09.002
0028-3908/© 2015 The Authors. Published by Elseviera b s t r a c t
Brain injury generates the release of a multitude of factors including extracellular nucleotides, which
exhibit bi-functional properties and contribute to both detrimental actions in the acute phase and also
protective and reparative actions in the later recovery phase to allow neuroregeneration. A promising
strategy toward restoration of neuronal function is based on activation of endogenous adult neural stem/
progenitor cells. The implication of purinergic signaling in stem cell biology, including regulation of
proliferation, differentiation, and cell death has become evident in the last decade. In this regard, current
strategies of acute transplantation of ependymal stem/progenitor cells after spinal cord injury restore
altered expression of P2X4 and P2X7 receptors and improve functional locomotor recovery. The
expression of both receptors is transcriptionally regulated by Sp1 factor, which plays a key role in the
startup of the transcription machinery to induce regeneration-associated genes expression. Finally,
general signaling pathways triggered by nucleotide receptors in neuronal populations converge on
several intracellular kinases, such as PI3K/Akt, GSK3 and ERK1,2, as well as the Nrf-2/heme oxigenase-1
axis, which speciﬁcally link them to neuroprotection. In this regard, regulation of dual speciﬁcity protein
phosphatases can become novel mechanism of actions for nucleotide receptors that associate them to
cell homeostasis regulation.
This article is part of the Special Issue entitled ‘Purines in Neurodegeneration and Neuroregeneration’.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Contents
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There are different situations, such as traumatic injury, neuro-
degenerative diseases or stroke events, which can compromise
neuronal function, thus disrupting the dynamic equilibrium of the
brain. In all these cases, brain repair is necessary and neuro-
regenerative mechanisms to restore neuronal function exist,
although most of them still remain unveiled. In addition, the hy-
pothesis that neurodegeneration is a failure of neuroregeneration,
increases the importance and complexity of the regenerative pro-
cess (Armstrong and Barker, 2001; Enciu et al., 2011; Gage and
Temple, 2013; Lim and Alvarez-Buylla, 2014). It is to emphasize
that a broad heterogeneity among adult neural stem cells exists,
their regional speciﬁcation emerging in early embryonic develop-
ment. The diverse and ﬁne-tuned molecular and biochemical
properties of stem cell types are essential for speciﬁc neurorepair,
but it is also part of the difﬁculty for a feasible clinical application
(Fuentealba et al., 2015; Merkle et al., 2014). There is not a clear
frontier between neuroregeneration and neuroprotection as many
compounds employed with neuroprotective purposes have also
been described as factors inducing neuronal proliferation and dif-
ferentiation. Thus, neuroprotection can be deﬁned as the mecha-
nisms trying to reduce secondary side effects of a large variety of
internal or external aggressions that require displaying speciﬁc
mechanisms for survival of neural cells. Among these aggressions,
attention will be paid to glutamate NMDA receptor-induced exci-
totoxicity, oxidative stress, genotoxic stress, decrease in brain
neurotrophins or estradiol and other neuroactive steroids (Arevalo
et al., 2015; Garcia-Yague et al., 2013; Hansen et al., 2002; Lastres-
Becker et al., 2014; Sofroniew et al., 2001). However, in spite of the
great advances in these areas, only a small fraction of their possi-
bilities are already known.
Since the beginning, extracellular nucleotides have proved to be
a solid evidence of playing a relevant role in neuroregeneration and
neuroprotection. A deep knowledge of their biology and the
signaling cascades mediated through P2 receptors activation is
necessary to understand how these substances are involved in
Central Nervous System (CNS) pathologies. Moreover, they offer an
opportunity of promising new drug targets, expanding the
boundaries of purinergic ﬁeld (Abbracchio et al., 2009; Burnstock,
2008, 2015b; Koles et al., 2011; North and Jarvis, 2013;
Zimmermann et al., 2012).
2. Involvement of purinergic receptors in CNS regeneration
CNS injuries caused by trauma, ischemia and stroke are complex
disorders associated with massive loss of neurons, and constitute
the principal cause of death and disability worldwide. Although
current pharmacological treatments and rehabilitative therapies
can improve neurological functions in some patients, it is frequent
that CNS lesions result in at least some incurable impairment even
with the best possible therapy. The main obstacle for neural repairis the limited regenerative capacity of injured neurons. Traumatic
brain injury induce release of ATP from damaged astrocytes, neu-
rons and endothelial cells, leading to the activation of purinergic
receptors coupled to protein kinase cascades that regulate
expression of genes implicated in long-term trophic actions, cell
survival and cell growth (Neary et al., 2006, 2005). Synergistic ac-
tions of nucleotides and growth factors stimulate astrocyte prolif-
eration, contributing to the process of reactive astrogliosis, which is
crucial for restriction of brain injury and regeneration of nerves and
glial cells in damaged area (Arthur et al., 2005; Franke, 2011;
Ishibashi et al., 2006). Moreover, brain injuries caused by trauma
or ischemia are also related to structural alterations of the axon
initial segment (AIS), which is not only the site of action potential
initiation but also plays an essential role in maintaining axon
integrity and identity (Bufﬁngton and Rasband, 2011; Hedstrom
et al., 2008; Kole et al., 2008). In physiological conditions, AIS
plasticity is controlled by the inﬂux of calcium through voltage-
gated calcium channels or glutamate receptors (Evans et al.,
2013). However, AIS disruption following middle cerebral artery
occlusion-induced brain ischemia takes place by a calcium-
dependent mechanism independent of NMDA receptors that can
be prevented by antagonism of P2X7 receptors (Del Puerto et al.,
2015). Furthermore, suppression or inhibition of P2X7 receptor
promotes axonal growth, suggesting a role of P2X7 antagonists in
axonal regeneration and axonal physiology (del Puerto et al., 2012;
Diaz-Hernandez et al., 2008). In addition, P2X7 and possibly other
purinergic receptors are emerging as important targets to interrupt
status epilepticus. Thus, inhibition of P2X7 receptors decreases
microglial activation and interleukin IL1b production as well as
reduces seizures during status epilepticus induced by intra-
amygdala microinjection of kainic acid (Engel et al., 2012).
Noticeable, the combination of benzodiazepines and P2X7 antag-
onists results in almost complete interruption of seizures in a mice
model of drug-resistant epilepsy (Engel et al., 2012).
2.1. Contribution of purinergic signaling in stem cell-based
neuroregeneration
A promising strategy toward restoration of neuronal function is
based on harnessing the innate mechanisms of the CNS for self-
repair and regenerate through activation of endogenous neural
stem/progenitor cells (NSPCs). NSPCs are multipotent cells that
self-renew, readily expand in vitro forming colonies of undifferen-
tiated cells called neurospheres, and are committed to the neural
lineage (Reynolds and Weiss, 1992). The implication of purinergic
signaling in stem cell biology, including regulation of proliferation,
differentiation, and cell death has become evident in the last
decade (Burnstock and Ulrich, 2011; Glaser et al., 2012; Ulrich et al.,
2012). Purinergic receptors are expressed in both neural stem cells
and neural progenitors from very early stages of frog, chick, and
mammalian embryonic development, suggesting their participa-
tion in the regulation of proliferation and lineage speciﬁcation
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proliferation and neurogenesis in neonatal and adult mouse ol-
factory epithelium (Jia and Hegg, 2010; Jia et al., 2009). Neuro-
spheres obtained from fetal rat brain express P2X2-P2X7 receptor
subunits, as well as P2Y1, P2Y2, P2Y4, and P2Y6 receptors (Burnstock
and Ulrich, 2011; Schwindt et al., 2011). Functional purinergic re-
ceptors have also been identiﬁed in the adult mammalian brain in
speciﬁc neurogenic niches, the subventricular zone (SVZ) of the
lateral ventricles and the subgranular layer of the hippocampal
dentate gyrus (Shukla et al., 2005). Neurospheres derived from the
adult mouse SVZ express P2X4 and P2X7 mRNA (Stafford et al.,
2007), and have functional P2Y1 and P2Y2 receptors. Activation of
these receptors increases cell proliferation in the presence of
growth factors and stimulates the migration of neural progenitors
isolated in vitro and expanded as neurospheres, which may be of
relevance for the local movement of cells in the neurogenic niches
(Grimm et al., 2010; Mishra et al., 2006; Scemes et al., 2003).
Moreover, P2Y1 receptor agonists reduce neurosphere size and
neurosphere-forming frequency of primary neurospheres derived
from adult mouse SVZ, allowing the possibility that a proportion of
the neural progenitor cell population differentiates into neurons
and glia (Stafford et al., 2007). The functionality of extracellular
nucleotides is tightly controlled by ecto-nucleotidases, which are
plasma membrane-bound enzymes with catalytic sites facing
extracellular medium (Zimmermann et al., 2012). Nucleoside
triphosphate diphosphohydrolase type 2 (NTPDase2), which cata-
lyzes dephosphorylation of nucleoside triphosphates and di-
phosphates generating the respective nucleoside monophosphate,
is highly expressed on adult neural progenitor cells of the SVZ and
hippocampus but is absent on astrocytes or mature neurons (Braun
et al., 2003; Shukla et al., 2005). Recent ﬁndings demonstrate that
NTPDase2 plays a major role in controlling extracellular nucleotide
concentrations in the neurogenic niches thereby acting as a ho-
meostatic regulator of nucleotide-mediated neural progenitor cell
proliferation and expansion under basal conditions (Gampe et al.,
2015).
2.2. Role of purinergic signaling in novel spinal cord injury repair
strategies
One of the major causes of physical disability worldwide pro-
duced by SNC lesion is the spinal cord injury (SCI), which involves
an irreversible loss of function distal to the lesion (paralysis) as a
result of axonal damage, demyelination, and death of oligoden-
drocytes, astrocytes, and neurons, including both spinal cord in-
terneurons and motor neurons (Grossman et al., 2001; Hulsebosch,
2002). SCI occurs with a worldwide incidence of 15e40 cases per
million people annually, which is more than 130,000 patients per
year, and frequently affects to young adults (Furlan et al., 2009;
Tator, 1995). Although no effective treatment currently exists for
the mayor neurological deﬁcits after SCI, there are several hopeful
neuroprotective agents being investigated in ongoing clinical trials
(Kwon et al., 2011; Tator et al., 2012). One of these promising
treatment strategies consists of NSPCs transplantation for pro-
moting spinal cord healing (Mothe and Tator, 2013). Ependymal
stem/progenitor cells (epSPCs) are multipotent stem cells found in
the periventricular region containing the central canal of the adult
spinal cord (Ronaghi et al., 2010). Following SCI, epSPC progeny is
recruited to the injury site, evenwhen the injury does not affect the
epSPCs or their processes, giving rise among others to new oligo-
dendrocyte progenitor cells (Meletis et al., 2008). The intrinsic
potential of epSPCs to replace some of the cells in the spinal cord
after injury opens up the opportunity for developing non-invasive
therapies for patients with SCI, through activating the differentia-
tion of epSPCs into various cell types. An in vitro study in mice hasshown that the manipulation of epSPCs after SCI might be a viable
strategy for restoring neuronal dysfunction in humans. Thus, using
speciﬁc differentiation protocol, 90% of differentiated cultures of
epSPCs obtained after SCI stain positive for the motor-neuron-
speciﬁc marker HB9, with 32% of these motor neurons displaying
electrophysiological properties that resemble those of functional
spinal motor neurons (Moreno-Manzano et al., 2009). Trans-
plantation of adult spinal-cord derived neurospheres from healthy
donors was ﬁrst shown to slightly improve motor recovery with
aberrant axonal sprouting associated with allodynia. However,
acute transplantation of epSPCs cultured from spinal cord injured
donors (ependymal stem/progenitor cells after injury, epSPCis) is
able to efﬁciently reverse the paralysis associated with SCI in rats
(Moreno-Manzano et al., 2009). Following SCI, large amounts of
ATP and other nucleotides are released by the traumatized tissue
leading to the activation of purinergic receptors that, in coordina-
tion with growth factors, induce lesion remodeling and repair
(Burnstock and Ulrich, 2011; Glaser et al., 2012). On the other hand,
blockade of purinergic receptors after SCI reduces the gliosis
response and diminishes also the formation of a glial scar
(Rodriguez-Zayas et al., 2012). A recent work shows that epSPCs
express functional ionotropic P2X4 and P2X7, and metabotropic
P2Y1 and P2Y4 receptors, able to respond to ATP, ADP, and other
nucleotidic compounds (Gomez-Villafuertes et al., 2014). Further-
more, a comparative study between epSPCs cultured from healthy
rats versus epSPCis, obtained from rats that one week earlier suf-
fered an SCI, reveals that a downregulation of P2Y1 receptor
together with an upregulation of P2Y4 receptor occur in epSPCis
(Gomez-Villafuertes et al., 2015). These ﬁndings suggest that the
expression levels of P2Y receptors may play a critical role in the
modulation of neural progenitor cell expansion. In support of this
idea, some reports demonstrate that purinergic signaling might be
required not only for developmental progenitor cell expansion and
neurogenesis, but also to maintain NSPCs niches in the adult brain.
External addition of ATP or its analogs increases the mitotic index
and rate of neural progenitor cells, whereas P2Y antagonists sup-
press both neurosphere expansion and the mitotic index of cells
within those neurospheres (Lin et al., 2007). Remarkably, severe
traumatic spinal cord contusion induces early and persistent in-
crease in the expression of P2X4 and P2X7 receptors around the
injury, which can be completely reversed by acute transplantation
of undifferentiated epSPCis, correlating with a functional locomotor
recovery in a rat model of SCI (Gomez-Villafuertes et al., 2015).
2.3. Nuclear factors involved in nerve regeneration
Injured neurons have the ability to switch the expression of
regeneration-associated genes (RAGs) on and off according to the
regeneration program (Raivich and Makwana, 2007; Sun and He,
2010). Numerous injury-inducible transcription factors have been
identiﬁed to date, including c-Jun, sox11, CREB, Smad1, ATF3,
AKRD1, NFIL3, p53, STAT3, C/EBPb, and several KLF family members
(Kiryu-Seo and Kiyama, 2011). However, it is required to know how
such a large number of transcription factors interplay with each
other to regulate RAGs synchronously, and how global and dynamic
changes in gene expressions are controlled. In this line of thought,
damage-induced neuronal endopeptidase (DINE) is considered to
be an ideal representative gene to provide further information
about how injury-inducible transcription factors cooperate with
each other during nerve regeneration (Kiryu-Seo and Kiyama,
2004). The most intriguing property of DINE is its extreme tran-
scriptional response against various kinds of peripheral and central
nerve injuries, including motor, sensory and sympathetic nerve
injuries, brain and spinal cord trauma, and brain ischemia
(Boeshore et al., 2004; Kiryu-Seo et al., 2000). The enhanced
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seen in glial cells. Co-expression of activating transcription factor 3
(ATF3), c-Jun, and signal transducer and activator of transcription 3
(STAT3) increased the DINE promoter activity, although these
transcription factors do not directly bind to a speciﬁc element
within the promoter. Instead, speciﬁcity protein 1 (Sp1) transcrip-
tion factor directly binds with high afﬁnity to GC-rich DNA se-
quences located in the region proximal to the transcription start
site of the DINE promoter, functioning as a scaffolding protein to
recruit c-Jun, ATF3, and STAT3 to elicit their functional synergy
(Kiryu-Seo et al., 2008). Importantly, the mechanism by which Sp1
may provide c-Jun/ATF3/STAT3 with a platform would be practical
and effective when increased gene expression is required in the
event of a fatal emergency such as neuronal injury (Fig. 1). Sp1 is a
multifunctional protein that, at the transcriptional level, is not
induced in injured neurons, but is expressed constitutively. The
accessibility of injury-inducible transcription factors is determined
by the modiﬁcation of Sp1, suggesting the possibility that different
alterations of Sp1 recruit different injury-inducible transcription
factors. The activity and stability of Sp1 is regulated at the protein
level by post-translational modiﬁcations, including phosphoryla-
tion, acetylation, sumoylation, ubiquitination, and glycosylation
(Hung et al., 2006; Tan and Khachigian, 2009). The activity of Sp1 is
also modulated by interactions or interplay with other transcrip-
tion factors such as p53, c-myc, Smad, AP-2, and E2F-1 (Wierstra,
2008). These additional transcription factors may participate in
the Sp1/c-Jun/ATF3/STAT3 complex to yield maximum effects in
injured neurons. Considering that the expression of some puri-
nergic receptors implicated in CNS regeneration, such as P2X4 and
P2X7 receptors, is transcriptionally regulated by Sp1 in basal con-
ditions (Garcia-Huerta et al., 2012; Korenaga et al., 2001), we can
speculate that nerve-injury transcription factors could be capable
of enhancing P2X expression under pathological situations, simi-
larly to what happens with RAGs. The majority of P2X4-positive
cells following spinal cord lesion has been identiﬁed as activatedFig. 1. Possible mechanism of Sp1-mediated transcriptional complex to induce the expressio
damage, brain/spinal cord trauma or cerebral ischemia, the injury-inducible transcription fa
recruit the heterodimer ATF3/cJun and Stat3. The activity of Sp1 is regulated by post-translati
and glycosylation. Moreover, interaction with other transcription factors and chromatin m
induces the expression of RAGs such as damage-induced neuronal endopeptidase (DINE) o
Kiyama, 2011).microglia/macrophages and surviving neurons/neurites (Schwab
et al., 2005). The expression of P2X4 receptors is also elevated in
spinal cord microglia after peripheral nerve injury (Tsuda et al.,
2003; Ulmann et al., 2008), and P2X4 knock-out mice have lower
levels of neuroinﬂammation after SCI, resulting in signiﬁcant
improvement in tissue sparing and functional recovery, especially
during the ﬁrst week after injury (de Rivero Vaccari et al., 2012).
Concerning P2X7 receptor, a post-ischemic, time-dependent
upregulation of this receptor in neurons and glial cells has been
demonstrated in a focal cerebral ischemia rat model, suggesting a
key role for this receptor in the pathophysiology of cerebral
ischemia in vivo (Franke et al., 2004). However, the relationship
between P2X7 receptor expression and the pathogenesis of con-
tusive SCI remains controversial. Some evidences indicate that
blockade of P2X7 receptors improve both the functional and
pathological consequences of SCI (Peng et al., 2009; Wang et al.,
2004), whereas others conclude that P2X7 receptor antagonism
fails to improve motor recovery or histopathological outcome
(Marcillo et al., 2012). P2X7 receptor arouses special interest due to
its dual function as an inhibitor of neurogenesis and axon
outgrowth and inductor of cell death in other cases. In cultured
hippocampal neurons and differentiated neuroblastoma cells
axonal growth and branching is induced following P2X7 receptor
inhibition (Fig. 2) (Diaz-Hernandez et al., 2008; Gomez-Villafuertes
et al., 2009), whereas a strong activation of P2X7 receptor causes
necrosis/apoptosis in both embryonic and adult neural progenitor
cells (Delarasse et al., 2009; Messemer et al., 2013). Interestingly, it
is suggested that cell death elicited by P2X7 receptor activationmay
counter-regulate progenitor cell survival after CNS injury, where
excessive neuro- and gliogenesis is induced (Messemer et al., 2013).
3. Involvement of purinergic receptors in neuroprotection
In processes related to brain injury, nucleotide receptor activity
accounts for changes and adaptations in different cell populations.n of regeneration-associated genes (RAGs) in response to nerve injury. Following nerve
ctor ATF3 binds to cJun and both enter the nucleus. There, Sp1 provides a platform to
onal modiﬁcations including phosphorylation, acetylation, sumoylation, ubiquitination,
odiﬁers participate and modulate the transcriptional machinery mediated by Sp1 that
r some P2X receptor genes in response to nerve injury (adapted from Kiryu-Seo and
Fig. 2. Sp1-dependent expression of P2X7 receptor regulates axonal growth and branching in differentiated neuroblastoma cells. Immunoﬂuorescences for P2X7 receptor (green,
upper panel), Sp1 (green, lower panel) and a-tubulin (red) in Neuro-2a cell line cultured in serum-free medium for 72 h. Nuclei were counterstained with DAPI (blue). Merged
channels are also shown. Confocal images were acquired with a TCS SPE microscope from Leica Microsystems with an Apochromat 63X, 1.3 NA oil immersion objective (Wetzlar,
Germany). Scale bar ¼ 15 mm.
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ATP released. Until now, the increased purinergic signaling that
follows CNS damage has been considered to contribute to devel-
opment and maintenance of the subsequent inﬂammatory
response. Therefore, it is not surprising that design of new puri-
nergic ligands of therapeutic potential is usually based on antago-
nistic action on both P2X and P2Y receptors (Burnstock et al., 2011;
Franke et al., 2012). Nevertheless, many examples of protective and
trophic actions of purinergic agonists are emerging, adding new
clues to the role of these receptors in animal models of neurode-
generative diseases, ischemic stroke and SCI (Chen and Brosnan,
2006; Delarasse et al., 2011; Hracsko et al., 2011; Marcillo et al.,
2012; Monif et al., 2009). Moreover, purinergic receptors do not
only mediate neuroprotection but also play active role in neuro-
genesis (Gampe et al., 2015; Ulrich and Illes, 2014). Therefore, it
appears that some nucleotidic actions can also be crucial for pre-
paring the required environmental conditions prior to subsequent
processes of remodeling and repair once the inﬂammatory ampli-
ﬁcation phase has occurred. The overall data concerning these
functions implies that special caution has to be taken when using
drugs or pharmacological tools that systematically block these re-
ceptors. In fact, whether nucleotide receptor activation is beneﬁcial
or detrimental depends on a great deal of factors, including the
nature of the toxic insult and the speciﬁc tissue cell population,
both converging in a precise temporal window of the injury event.
3.1. Neuroprotective signaling triggered by P2X nucleotide receptors
Understanding of nucleotide neuroprotective role requires a
model of study that provides a speciﬁc physiological niche inwhich
controlled activation of nucleotide receptors lead to positive
outcome. Primary cultures of cerebellar granule neurons represent
one of the most popular in vitro models to study neuronal differ-
entiation and survival. Indeed, cultured granule cells after 7 days
in vitro acquire several electrophysiological and biochemicalfeatures of mature neurons (Burgoyne et al., 1993; Contestabile,
2002). In addition, trophic requirements operating for differentia-
tion and maturation of cells in culture are the same than those
occurring in vivo during development and migration of granule
neurons. The most potent trophic factors, such as brain-derived
neurotrophic factor (BDNF), basic ﬁbroblast growth factor (bFGF),
and insulin-like growth factor 1 (IGF-I), trigger survival routes that
mainly involve PI3K/Akt axis and MAPK activation. In addition,
neuronal survival is highly dependent on synaptic activity and any
signal promoting increase in intracellular calcium concentration is
essential for the proper cell survival and differentiation
(Contestabile, 2002). In this regard, different P2X and P2Y receptors
expressed in these cells contribute to maintain survival conditions
through their coupling to calcium signaling (Hervas et al., 2003;
Sanchez-Nogueiro et al., 2009).
Among different nucleotidic receptors, P2X7 seems to play a
relevant role in granule neuron physiology. In this respect, [Ca2þ]i
measurements performed in mouse granule cell ﬁbers in response
to ATP or the P2X7 receptor agonist 30-O-(4-benzoyl)benzoyl-ATP
(BzATP) are ionotropic in nature and correspond to the character-
istics of a P2X7 receptor (Sanchez-Nogueiro et al., 2009, 2005).
Interestingly, the elusive responses to BzATP are only detectable
when electrophysiological recordings are performed in cells bathed
in a medium lacking Ca2þ and Mg2þ, therefore avoiding the
inhibitory effect of extracellular divalent cations on P2X7 receptor
activation (Coddou et al., 2011; North, 2002). Under these condi-
tions, non-desensitizing currents triggered by BzATP administra-
tion correspond unequivocally to those caused by P2X7 receptors.
In addition, BzATP also induces [Ca2þ]i elevations in both cell
somata and axodendritic ﬁbers of mouse granule neurons in
stringent conditions of Mg2þ-free solution, being sensitive to Bril-
liant Blue G (BBG) and A-438079 speciﬁc P2X7 antagonists
(Sanchez-Nogueiro et al., 2014). Accordingly, calcium transients
induced by ATP in rat synaptic terminals isolated from adult rat
cerebellum correlate well with responses exhibiting a
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2005). Overall, these results support the presence of functional
P2X7 receptors with their peculiar features in cerebellar granule
neurons.3.1.1. P2X receptor coupling to glycogen synthase kinase 3 (GSK3)
signaling. Interaction with growth factors
Studies on nucleotide receptors signaling reveal that both P2X
and P2Y subtypes activate signaling cascades characteristic of tro-
phic factors in granule neurons. In this model, ATP stimulation
activates GSK3 phosphorylation at Ser9/21 residues (for b- and a-
GSK3 isoforms, respectively) and inhibits its catalytic activity. This
effect is characteristic of a low afﬁnity ATP receptor, as GSK3
phosphorylation increased with ATP concentrations reaching the
mM range. The receptor involved matches well with the pharma-
cological proﬁle of a P2X7 receptor. Firstly, GSK3 phosphorylation is
dependent on extracellular calcium concentration, fully activated
by BzATP, and abolished in the presence of BBG and A-438079
(Ortega et al., 2009). Secondly, GSK3 phosphorylation is signiﬁ-
cantly potentiated whenmeasured in medium lacking extracellular
divalent cations such as Ca2þ and Mg2þ (Coddou et al., 2011; North,
2002).
In primary cultures of cerebellar granule neurons, the inhibition
of GSK3 activity induced by P2X7 receptors promotes neuro-
protection. Indeed, GSK3 activity is toxic for neurons, as many GSK3
substrates are active members of the mitochondrial apoptotic
cascade, such as the protein Bax (Hetman et al., 2000; Linseman
et al., 2004). Therefore, any trophic signal coupled to GSK3 phos-
phorylation and inhibition presents pro-survival activity (Chin
et al., 2005). Unexpectedly, P2X7 receptors provide a novel mech-
anism for GSK3 inactivation that is dependent on protein kinase C
(PKC) and by-pass the classical phosphoinositide 3-kinase (PI3K)/
Akt-dependent route used by growth factors (Ortega et al., 2009).
Moreover, this activity conveys an alternative pathway displayed byFig. 3. P2X7 receptor mediated signaling associated to neuroprotection. Signaling activated b
of ERK1,2-MAPK via Ca2þ-CaMKII provides a route of CREB phosphorylation and activation
protection against glutamate-induced excitotoxicity. In addition, a novel mechanism of GSK
Akt/GSK3 axis classically triggered by growth factors. This mechanism of action allows P2X7
receptors also present the ability to couple to PKC/GSK3 alternative route when the usual P
enhancing survival when combined with BDNF and NMDA receptor stimulation.P2X7 receptors to maintain survival in conditions of inactivation of
the main PI3K/Akt axis. This apoptotic paradigm can occur during
trophic factor deprivation, and can be experimentally mimicked
through pharmacological inhibition of PI3K activity with the
compound LY294002 (D'Mello et al., 1993; Hetman et al., 2000;
Miller et al., 1997). In this regard, under conditions of exposure to
LY294002, the stimulation of P2X7 receptors rescues granule cells
from apoptosis and prevents the increase in caspase-3 and GSK3
catalytic activity (Ortega et al., 2009). This neuroprotective effect
requires GSK3 phosphorylation via PKC, speciﬁcally calcium-
dependent PKC subtypes expressed in granule neurons (Popp
et al., 2006). In other cell populations, such as cortical astrocytes,
GSK3 signaling mediated by different nucleotide receptors also
follows the PKC-dependent pathway (Neary and Kang, 2006). In
contrast to the granule neurons scenario, nucleotides acting at
P2X7 receptors are able to couple to canonical PI3K/Akt signaling,
which can promote survival and proliferation of cortical astrocytes
after mechanical strain caused injury (Neary et al., 2005). Other
trophic signals in granule neurons, such as BDNF and moderate
stimulation of NMDA receptors are also coupled to either PI3K or
PKC to phosphorylate and inhibit GSK3 activity, therefore contrib-
uting to neuronal survival in conditions of PI3K inactivation (Fig. 3)
(Ortega et al., 2010; Zirrgiebel et al., 1995). Similarly, sub-maximal
activation of NMDA receptors in cortical neurons also elicits sur-
vival by maintaining inhibition of GSK3 activity through PI3K in-
dependent mechanisms (Habas et al., 2006). These results indicate
that alternative signaling routes can be triggered to promote sur-
vival when the main pro-survival PI3K/Akt pathway is non-
functional and nucleotides released to the extracellular space
behave as important signals to assure minimum levels of survival.
As previously mentioned, GSK3 acts as a convergence point for
several pro-survival factors that assure ﬁne tuning of GSK3 activity
(Chin et al., 2005). Interestingly, positive interactions of P2X7 re-
ceptors with NMDA and BDNF receptors also occur in granuley P2X7 receptors in granule neurons links to calcium-dependent events. The activation
, which mediates transcription of pro-survival genes. This pathway is responsible of
3 phosphorylation involves calcium dependent-PKCs that by-pass the canonical PI3K/
receptor to maintain survival in conditions of PI3K inactivation. As well, TrkB and NMDA
I3K/Akt axis is not functional. Additionally, P2X7 receptors exhibit a priming effect by
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induced by PI3K inactivation. In agreement with this, both P2X7
and NMDA receptors exhibit some degree of synergism on GSK3
phosphorylation (Fig. 3) (Ortega et al., 2010). This positive interplay
already described for P2X7 receptors reaches particular relevance
in granule neurons, providing alternative routes to support cell
survival in conditions of limiting growth factor availability or
reduced synaptic activity.
It is to notice that functional relationship between NMDA and
BDNF receptors also occurs in granule neurons implying BDNF
synthesis and release induced by NMDA receptor activation. Taking
into account the similarities between the properties and behavior
of NMDA and P2X7 receptors it cannot be excluded that P2X7 re-
ceptors could also participate in this autocrine loop connecting
trophic and protective effects of BDNF to synaptic activity (Bazan-
Peregrino et al., 2007; Marini et al., 1998; Zhu et al., 2002). In this
support, several other examples in the literature concerns inter-
action between ionotropic P2X receptors and tropomyosin receptor
kinase B (TrkB). Again, neuroprotective actions are attributed to
P2X7 receptors on the basis of release of BDNF from Schwann cells
(Verderio et al., 2006). In addition, in microglial cells from spinal
cord, such level of cooperativity with BDNF has already been
described for P2X4 receptors. In this occasion, through a Ca2þ and
p38-dependent pathway, P2X4 receptors stimulates synthesis and
release of BDNF, which behaves as a key molecule in microglia-
neuron signaling and contributes to development of tactile allo-
dynia (Trang et al., 2006; Tsuda et al., 2003).
3.1.2. P2X receptor coupling to mitogen-activated protein kinase
(MAPK) signaling
As described for GSK3 phosphorylation, trophic activity of P2X7
receptor in granule neurons also accounts for coupling to extra-
cellular signal-regulated kinases ERK1,2-MAPKs, Again, BzATP
stimulates ERK1,2 phosphorylation with the pharmacological pro-
ﬁle of a P2X7 receptor activation. In this case, the effect directly
relates to P2X7-stimulated calcium signaling and is dependent on
Ca2þ/calmodulin-dependent protein kinase II (CaMKII) activity
(Leon et al., 2006; Ortega et al., 2011). Activation of ERK1,2 pathway
contributes to survival against excitotoxic concentrations of gluta-
mate (Fig. 3) (Ortega et al., 2011). Once more, BDNF shares with
BzATP this pro-survival activity that is strongly dependent on the
phosphorylation and activation of cAMP response element-binding
protein (CREB), a well-known ERK1,2 target in granule neurons
(Marini et al., 2004; Monti et al., 2002). In contrast, this survival
pathway is stimulus-dependent, as P2X7 receptor-dependent
ERK1,2 signaling does not protect from apoptosis induced by PI3K
inactivation. These data support the notion that trophic signals as
well as extracellular nucleotides can discriminate among distinc-
tive transducing mechanisms to overcome different kinds of
apoptotic insults (Hetman et al., 1999).
Another interesting cytoprotective role assigned for P2X7 re-
ceptors that involved the MAPK signaling is also ascribed to rat
brain microglial cells. In this model, ATP activation of P2X7 re-
ceptors stimulates expression and release of tumor necrosis factor
(TNFa). The presence of this cytokine in the extracellular medium
seems to be beneﬁcial as it contributes to the protection of sur-
rounding neurons against glutamate-induced cell death (Hide et al.,
2000; Suzuki et al., 2004).
3.2. Neuroprotective signaling triggered by P2Y nucleotide
receptors
Concerning metabotropic P2Y receptors, extensive data exist in
the literature that directly associate them to neuroprotective ac-
tions under different pathological conditions. Among them, P2Y2receptors behave as key players in astrocytic cells through the
activation of multiple signaling cascades to elicit survival. PI3K-
dependent activation of ERK, Akt and CREB signaling proteins
plays a predominant role in survival after traumatic injury,
contributing to upregulation of pro-survival proteins of the bcl
family and downregulation of pro-apoptotic factors, such as Bad
(Burgos et al., 2007; Chorna et al., 2004). In addition P2Y2 receptors
become upregulated during neuroinﬂammation and mediate pro-
tective and reparative functions through the activation of multiple
intracellular pathways that involve growth factor receptor
signaling cascades, nuclear factor kB (NFkB), MAPKs and tyrosine
kinases in neuronal and glial cells (Weisman et al., 2012).
P2Y1 receptors are also abundantly expressed in neurons and
astrocytes of different brain regions and modulate important
functions in pathophysiology. The activation of PI3K/Akt and MAPK
signaling pathways are mediating processes like astrogliosis, pro-
liferation and survival (Franke et al., 2012). Similarly, interleukin IL-
6 released from astrocytes acts as a survival factor for hippocampal
neurons submitted to oxidative stress (Fujita et al., 2009).
3.2.1. GSK3 and MAPK signaling routes in neuroprotection
Again, granule neurons provide evidence of P2Y receptor
signaling coupled to neuroprotection. In this regard, PI3K/Akt/GSK3
pathway is targeted for a special type of ADP-P2Y responding re-
ceptor that is insensitive to P2Y1 antagonists. The pharmacological
proﬁle for GSK3 phosphorylation induced by the non-hydrolyzable
analog 2MeSADP in these cells corresponds to the activation of the
more recently characterized P2Y13 receptor, as was consistent with
a Gi-coupled activity (Ortega et al., 2008). Of particular relevance is
the novel association of the P2Y13-coupled signaling pathway to the
antioxidant Nrf-2/heme oxigenase-1 axis. This mechanism of action
is dependent on GSK3 inhibition, which prevents negative regula-
tion of the nuclear factor erythroid 2erelated factor 2 (Nrf-2).
Subsequent Nrf-2 nuclear accumulation regulates transcription of
phase-2 antioxidant genes (Rada et al., 2012; Rojo et al., 2008). This
pathway directly links P2Y13 receptors to neuroprotection against
oxidative stress (Espada et al., 2010). In agreement with these re-
sults, P2Y13-mediated GSK3 inhibition also prevents phosphoryla-
tion and degradation of the GSK3 substrate, b-catenin. This
transcriptional regulator can then accumulate into the nucleus and
induce the expression of several genes involved in survival and
differentiation (Fig. 4) (Ortega et al., 2008). In addition, P2Y13 re-
ceptors also activate ERK1,2-dependent signaling and prevent cell
death and caspase-3 activation in conditions of glutamate induced
excitotoxicity. Again, the phosphorylation of CREB transcription
factor plays an essential role in this pro-survival effect (Fig. 4)
(Ortega et al., 2011). ADP metabotropic signaling through P2Y1 and
P2Y13 receptors has also been reported in different populations of
cerebellar astrocytes. In both neurons and astrocytes, GSK3 and
ERK-1,2 signaling seems to be speciﬁcally triggered by P2Y13 re-
ceptors that mediate trophic and pro-survival effects and exceed
the role and function of P2Y1-mediated activity (Perez-Sen et al.,
2015).
3.2.2. Relevant role of dual speciﬁcity protein phosphatases (DUSP)
in neuroprotection
As mentioned above, neuroprotective role for nucleotide re-
ceptors deals with direct action on key kinase cascades. Novel
signaling mechanisms are emerging, which involve protein phos-
phatases as new targets for nucleotide receptors and connect them
to cell homeostasis and explain some protective effects.
In this regard, a new role for P2Y13 receptors in granule neurons
conveys the regulation of expression of a particular member of dual
speciﬁcity protein phosphatases, DUSP2, which sequentially
recognize both Ser/Thr and Tyr residues. Namely, DUSP2 belongs to
Fig. 4. P2Y13 receptor mediated signaling associated to neuroprotection. P2Y13 receptors promote neuroprotective actions through their coupling to classical survival kinases, such
as GSK3 and ERK1/2, as well as protein phosphatases. P2Y13 receptors activation of canonical PI3K/Akt/GSK3 pathway allows the cytosolic accumulation of the GSK3 substrates, b-
catenin and the transcription factor Nrf-2. Both translocate to the nucleus where they regulate the expression of genes related to anti-apoptotic actions. Specially, the expression of
heme-oxigenase-1 (HO-1) explains the protective role of P2Y13 against oxidative stress. In addition, P2Y13 receptors also activate ERK1,2 signaling in a way dependent on PI3K
activity. Among different proteins, dual speciﬁcity protein phosphatase-2 (DUSP2) resulted to be a speciﬁc target of gene expression activated by ERK1,2. The latter represents a
novel mechanism of action by which P2Y13 receptors participate in negative feedback regulation of MAPK signaling. In line with this, they assure recovery of basal levels of
phosphor-p38 increased in response to genotoxic stress. Therefore, P2Y13 receptors can function as essential players in cell homeostasis and survival in neurons.
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MAP kinases as substrates (MKPs, MAPK phosphatases). According
to its behavior as an immediate-early gene, dusp2 is rapidly induced
and its expression depends on ERK1,2-mediated signaling stimu-
lated by P2Y13 receptors. This mechanism of action allows P2Y13
receptors to participate in feedback negative regulation of MAPK
signaling in neurons. In addition, regulation of DUSP2 expression
contributes to the pro-survival activity of P2Y13 receptors against
genotoxic stress induced by cisplatin (Fig. 4). Cytotoxic action of
this drug increases phosphorylated levels of p38 stress-related
MAPK, which steadily accumulates into the nucleus. The time-
course of DUSP2 protein expression elicited by P2Y13 receptor
activation correlates well with the recovery of low basal levels of
the phosphorylated form of nuclear p38 (Fig. 5) (Morente et al.,
2014).
While P2Y13 receptors seem to play a fundamental role in
cerebellar cells, in cortical astrocytes another ADP responding re-
ceptor P2Y1 functions to regulate the expression of protein tyrosine
phosphatase. It is to notice that this signaling mechanism con-
tributes to suppress ERK1,2 hyper-activation elicited by oxidative
stress and in addition to protect against cell death (Shinozaki et al.,
2005, 2006).
The regulation of protein phosphatase activities and expression
by nucleotide P2Y1 and P2Y13 receptors opens new insights into the
function of nucleotide receptors as main regulators of cell signaling
homeostasis. Therefore, they can have potential implications in
disorders characterized by marked alterations of MAPK signaling,
such as ischemia, neurological disorders, as well as tumor pro-
gression and metastatic processes. In addition, this new role sup-
ports the general view that ADP-P2Y receptors exert a protective
role in several cell populations. The regulation of diverse protein
phosphatase families by nucleotide receptors can be a general
mechanism of action that extends their pro-survival activity indifferent models. Future work will be necessary to fully understand
the potential role of protein phosphatases, mainly the family of dual
speciﬁcity phosphatases, as new pharmacological targets.
3.3. Physiological meaning of nucleotide receptor signaling in
neurons
All data reviewed here support the role of nucleotide receptors
displaying trophic signaling to maintain proper functioning and
survival in cell models of CNS. Among different mechanisms, GSK3
and ERK1,2 signaling pathways are gaining particular relevance and
associate nucleotide receptors with neuroprotective actions.
At this point, it is necessary to emphasize that other studies have
reported toxic actions for ATP and other nucleotide analogs in
different neuronal and glial populations (Volonte et al., 2003).
Speciﬁc culture conditions can provide distinct maturation stages
with a particular environmental niche, which greatly inﬂuences
receptors expression, heteromer formation and their coupling to
diverse signaling partners. Besides environmental factors, nucleo-
tide receptor isoforms can account for these apparent discrep-
ancies. This is particularly striking for P2X7 receptors in which a
high degree of heterogeneity has been found inmediated responses
and ﬁnal outcome (Sperlagh and Illes, 2014). Not only P2X7 re-
ceptors are highly polymorphic and revealed both loss- and gain-of
function activities among the different forms, but also several
mouse and human splice variants have been reported that include
some truncated isoforms coexisting in the same cell, and some of
them can escape from genetic knock-down of transgenic models.
Moreover, it cannot be excluded that notable differences at the level
of P2X7 receptor density in different strains of rodent species can
account for opposing effects (Adinolﬁ et al., 2010;
Cheewatrakoolpong et al., 2005; Masin et al., 2012; Miller et al.,
2011; Nicke et al., 2009; Sluyter and Stokes, 2011). As an example,
Fig. 5. Dual speciﬁcity protein phosphatase activation by P2Y13 receptors in neurons. A) Immunoﬂuorescence images depicts an increased expression of the nuclear inducible
DUSP2 protein phosphatase (green) after P2Y13 receptor activation by 2MeSADP analog in granule neurons, and merge with DAPI nuclear dye (blue). B) Confocal images of DUSP2
(green) and phosphor-p38 (red) staining of granule neurons show rapid accumulation of phosphor-p38 at the nucleus when exposed to genotoxic stress induced by cisplatin. The
increased expression of DUSP2 phosphatase triggered by 2MeSADP decreases phosphor-p38 levels at the nucleus counterstained with DAPI (blue). Confocal images were obtained
with a TCS SPE microscope from Leica Microsystems with a 20X objective (Wetzlar, Germany). Scale bar ¼ 20 mm.
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mouse P2X7 responses, concerning the sensitivity to ATP, the
physiological agonist, the magnitude of ionic currents elicited by
BzATP, and other cell changes produced after prolonged stimulation
of P2X7 receptors. The magnitude and current density of the non-
desensitizing currents elicited by nucleotides in mouse cerebellar
astrocytes are higher than those from rat cerebellar astrocytes.
Another distinctive feature of BzATP currents from mouse cere-
bellar astrocytes is the progressive increase in the fractional
permeability to N-methyl-D-glucamine (NMDGþ) during prolonged
nucleotide stimulation. In fact, sustained BzATP application induces
a gradual increase in membrane permeability to large cations, such
as NMDGþ and Yo-Pro-1, which ultimately led to the death of
mouse astrocytes. Unexpectedly, neither membrane permeability
changes nor dye uptake occurs in rat cerebellar astrocytes under
the same experimental conditions (Carrasquero et al., 2009; Salas
et al., 2013). Instead, prolonged P2X7 stimulation in rat cerebellar
astrocytes induced trophic actions (Carrasquero et al., 2010). These
differences probably could rely on the different expression levels of
the P2X7 protein, the divergence in the sequence of the C-terminal
tail region between the rat and mouse P2X7 receptor orthologues
and on the accepted role of this intracellular domain in controlling
plasma membrane permeability following P2X7 receptor stimula-
tion (Costa-Junior et al., 2011; Chessell et al., 1998).
4. Future perspectives
As previously described, there is compelling evidence for a role
of extracellular nucleotides in neuroregeneration and neuro-
protection. However, this young and fertile ﬁeld still offers a narrow
view of all its potential. New technological approaches taking
advantage of the “-omics” will expand our basic knowledge about
biomedical relevance of nucleotides in brain functioning. Besides,new aspects of the cellular neurobiology of P2X and P2Y receptors
need to be understood. Among them, the role of P2X4 in lysosomes
and other subcellular organelles, the physiological meaning of the
presence of P2X7 at the nuclear membrane or the location of some
P2Y receptors in mitochondrial external membrane (Burnstock,
2015a). In addition, we have recently demonstrated the presence
of P2X6 subunit into the cell nucleus, where it interacts with the
splicing factor subunit SF3A1, modifying themRNA splicing process
(Diaz-Hernandez et al., 2015).
Another interesting aspect is related to the non-coding RNAs,
including microRNAs (miRNAs), which can control mRNA stability
and translation. miRNAs are very abundant, being unequally
distributed among individual neurons, and can act as possible
regulators of neuronal diversity and stability as well as modulators
of axonal growth and branching (Han et al., 2011; Holt and
Schuman, 2013; Kaplan et al., 2013). Currently, a few miRNA tar-
geting purinergic P2 receptors expression have been described.
miR-186 and miR-150 have been reported to down-regulate P2X7
expression in cancer epithelial cells, increasing cell viability (Zhou
et al., 2008). Recently it has been found that activation of the
P2Y2 receptor can attenuate inﬂammation in endothelial cells
through an increase in the expression of miR-22, which targets
intercellular adhesion molecule 1 (ICAM-1) mRNA (Gidlof et al.,
2015). A burst of scientiﬁc publications on miRNA acting on
nucleotide neurobiology and their effects on neurorepair and
neuroprotection are to be expected.
Epigenetic mechanisms, responsible for embryonic develop-
ment till the ﬁnal phenotype of neuron subtypes has been acquired,
and the plastic changes in the adult CNS are now in the very front of
Neuroscience. A ﬁrst approach has been made trying to identify the
different DNA methylation pattern in the brain of Alzheimer's dis-
ease patients and genetically modiﬁed animals (Sanchez-Mut et al.,
2013). However, there is no data available on the involvement of
M.T. Miras-Portugal et al. / Neuropharmacology 104 (2016) 243e254252DNA methylation in the control of the expression of purinergic
receptors, or other purinergic neurobiology components, in
neurodegenerative diseases or when neurorepair and neuro-
protection are necessary. From this perspective, the purinergic ﬁeld
is a fertile area expanding its boundaries.
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